The Role of Radiation Therapy In Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma is organized by American Society for Radiation Oncology (ASTRO) and will be held from Jan 31, 2018 - Jan 30, 2020.
The target audience for this medical event is radiation oncologists and radiation oncology residents. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credit.
Provides practitioners with clear guidelines for managing relapsed lymphomas and clear information about new targeted agents now in regular use.
Learning Objectives :
Upon completion of this activity, participants should be able to:
• Define the appropriate use of radiation in the management of refractory lymphoma.
Additional details will be posted as soon as they are available.
Radiation Oncology, Haematology